Obesity needs new definition, according to a global report from leading experts. They argue that people with excess body fat can still live healthy, active lives, calling for a shift in how we diagnose obesity. The current standard, which uses Body Mass Index (BMI) to label anyone above a score of 30 as obese, may misclassify many individuals.
Instead, the report, published in The Lancet Diabetes & Endocrinology, recommends distinguishing between "clinical obesity"—for those suffering from complications—and "pre-clinical obesity"—for individuals whodo not currently have health issues. Prof. Francesco Rubino of King’s College London emphasizes that obesity exists on a spectrum; while some individuals cope well, others face significant health challenges.
By exploring obesity's effects on vital organs and daily life issues, experts suggest reframing the disorder as a clinical concern needing appropriate treatment, like medication or weight-management advice, based on individual health assessments. A clear diagnosis method could enable both children and adults to receive targeted care while mitigating unnecessary interventions for less severe cases.
The changing landscape in weight-loss drug prescriptions, like Wegovy and Mounjaro, makes this new classification even more crucial. However, concerns linger about potentially limited funding focused predominantly on clinically obese individuals, leaving those with pre-clinical conditions at risk of being underserved. Overall, the report urges a careful, compassionate approach to obesity management that protects all patients, adequately reflecting their health status.
